Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Animal models of inflammatory bowel disease.
Hibi T, Ogata H, Sakuraba A. Hibi T, et al. Among authors: sakuraba a. J Gastroenterol. 2002;37(6):409-17. doi: 10.1007/s005350200060. J Gastroenterol. 2002. PMID: 12108674 Review. No abstract available.
An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatment.
Sakuraba A, Motoya S, Watanabe K, Nishishita M, Kanke K, Matsui T, Suzuki Y, Oshima T, Kunisaki R, Matsumoto T, Hanai H, Fukunaga K, Yoshimura N, Chiba T, Funakoshi S, Aoyama N, Andoh A, Nakase H, Mizuta Y, Suzuki R, Akamatsu T, Iizuka M, Ashida T, Hibi T. Sakuraba A, et al. Am J Gastroenterol. 2009 Dec;104(12):2990-5. doi: 10.1038/ajg.2009.453. Epub 2009 Sep 1. Am J Gastroenterol. 2009. PMID: 19724269 Clinical Trial.
Update on the management of ulcerative colitis.
Hoentjen F, Sakuraba A, Hanauer S. Hoentjen F, et al. Among authors: sakuraba a. Curr Gastroenterol Rep. 2011 Oct;13(5):475-85. doi: 10.1007/s11894-011-0216-6. Curr Gastroenterol Rep. 2011. PMID: 21789495 Review.
Management of inflammatory bowel disease: past, present and future.
Keyashian K, Annunziata ML, Sakuraba A, Hanauer S. Keyashian K, et al. Among authors: sakuraba a. Expert Rev Clin Immunol. 2012 May;8(4):303-5. doi: 10.1586/eci.12.13. Expert Rev Clin Immunol. 2012. PMID: 22607175 Review. No abstract available.
C-reactive protein is an indicator of serum infliximab level in predicting loss of response in patients with Crohn's disease.
Hibi T, Sakuraba A, Watanabe M, Motoya S, Ito H, Sato N, Yoshinari T, Motegi K, Kinouchi Y, Takazoe M, Suzuki Y, Matsumoto T, Kawakami K, Matsumoto T, Hirata I, Tanaka S, Ashida T, Matsui T. Hibi T, et al. Among authors: sakuraba a. J Gastroenterol. 2014 Feb;49(2):254-62. doi: 10.1007/s00535-013-0807-0. Epub 2013 Apr 20. J Gastroenterol. 2014. PMID: 23604570 Clinical Trial.
154 results